1865 related articles for article (PubMed ID: 10645715)
21. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
Bergerot I; Souchier C; Thivolet C
C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
[TBL] [Abstract][Full Text] [Related]
22. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
[TBL] [Abstract][Full Text] [Related]
23. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
24. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
26. Demonstration of islet cell antibodies in apparently non-insulin dependent diabetic patients; a marker for the later development of insulin dependency.
Katsura H; Itoh N; Hanafusa T; Kono N; Tarui S
Med J Osaka Univ; 1991 Mar; 40(1-4):67-71. PubMed ID: 1369659
[TBL] [Abstract][Full Text] [Related]
27. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
Castleden HA; Shields B; Bingley PJ; Williams AJ; Sampson M; Walker M; Gibson JM; McCarthy MI; Hitman GA; Levy JC; Hattersley AT; Vaidya B; Pearson ER
Diabet Med; 2006 Aug; 23(8):834-8. PubMed ID: 16911619
[TBL] [Abstract][Full Text] [Related]
28. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
[TBL] [Abstract][Full Text] [Related]
29. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
Schmidli RS; Colman PG; Harrison LC
J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
[TBL] [Abstract][Full Text] [Related]
30. Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.
Thivolet C; Nicolino M; Monbeig S; Estour B; Halimi S; Robert M; Orgiazzi J; Chatelain P;
Diabetes Metab; 2002 Sep; 28(4 Pt 1):279-85. PubMed ID: 12442065
[TBL] [Abstract][Full Text] [Related]
31. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
32. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
[TBL] [Abstract][Full Text] [Related]
33. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
[TBL] [Abstract][Full Text] [Related]
34. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
35. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
Maugendre D; Sonnet E; Derrien C; Le Golff MC; Grais MC; Allannic H; Delamaire M
Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic autoantibodies in Tunisian children with newly diagnosed type 1 diabetes.
Fakhfakh R; Haddouk S; Hadj Hamida YB; Kamoun T; Ayed MB; Hachicha M; Masmoudi H
Pathol Biol (Paris); 2008 May; 56(3):130-2. PubMed ID: 18178035
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
Borg H; Fernlund P; Sundkvist G
Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
[TBL] [Abstract][Full Text] [Related]
38. The detection of autoantibodies to pancreatic islet cells by immunoenzyme histochemistry.
Kohnert KD; Rjasanowski I; Hehmke B; Hamann J; Keilacker H; Michaelis D
Diabetes Res; 1994; 25(1):1-12. PubMed ID: 7648777
[TBL] [Abstract][Full Text] [Related]
39. Familial clustering of beta-cell autoimmunity in initially non-diabetic children.
Kukko M; Toivonen A; Kupila A; Korhonen S; Keskinen P; Veijola R; Virtanen SM; Ilonen J; Simell O; Knip M
Diabetes Metab Res Rev; 2006; 22(1):53-8. PubMed ID: 16100734
[TBL] [Abstract][Full Text] [Related]
40. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]